Table 1. General and clinical characteristics of the patients in the exercise and non-exercise groups.
Variable | Total | Exercise | Non-exercise |
---|---|---|---|
Mean±SD | Mean±SD | Mean±SD | |
N | 1,263 | 734 | 529 |
Age (yr) | 60.6±11.6 | 60.4±11.0 | 60.9±12.5 |
Height (cm) | 163.1±9.1 | 163.5±8.6 | 162.5±9.7 |
Weight (kg) | 67.0±11.4 | 66.6±11.0 | 67.6±11.9 |
BMI (kg/m2) | 25.1±3.3* | 24.9±3.1 | 25.5±3.6 |
Onset (yr) | 50.1±11.1 | 50.0±10.6 | 50.4±11.9 |
Duration of diabetes (yr) | 10.5±8.3 | 10.4±8.0 | 10.5±8.5 |
N (%) | N (%) | ||
Gender | |||
Male | 734 (58.1) | 440 (59.9) | 294 (55.6) |
Female | 529 (41.9) | 294 (40.1) | 235 (44.4) |
Hypertension | 625 (49.5)* | 342 (46.6) | 283 (53.5) |
Hyperlipidemia | 206 (16.3) | 109 (14.9) | 97 (18.3) |
Therapy of diabetes | |||
Diet | 48 (3.8) | 24 (3.3) | 24 (4.5) |
Oral agent | 895 (70.9) | 528 (71.9) | 367 (69.4) |
Oral agent+inulin | 236 (18.7) | 137 (18.7) | 99 (18.7) |
Insulin | 78 (6.2) | 43 (5.8) | 35 (6.6) |
Education experience | 773 (61.2)* | 469 (63.9) | 304 (57.5) |
Characteristics of the study population were investigated using medical records including disease-related data and data for blood sampling tests, prescription drugs, comorbidities, and complications. Each value is presented as the mean ± SD of the values measured during the survey. Statistical analysis was performed by using independent t-test. *p < 0.05